ARCHIVES

NIH RPG Success Rate to Fall Further

This article is from The Cancer Letter archive.

Vol. 39 No. 23 | June 7, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

Intramural Review System Described

September 10, 1982

Cooperative group chairman suggest changes to incentive system.

August 13, 2004

Perifosine Increases PFS In Phase II Study

December 30, 2011

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008